7 October 2013
Barclays PLC
Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a)
On 4 October 2013, Barclays PLC ("the Company") was notified that the following Directors of the Company (and persons connected with them) and PDMRs had, on 4 October 2013, acquired ordinary shares in the Company ("Shares") pursuant to the Company's rights issue (the "Rights Issue") at 185 pence per Share including in respect of the Barclays Global Sharepurchase Plan, the Barclays Sharepurchase Plan and Shares held for or on behalf of the Directors (and / or persons connected with them) and / or PDMRs in nominee accounts.
Director/PDMR
|
Shares acquired pursuant to the Rights issue |
David Booth |
24,461 |
Tim Breedon |
1,336 |
Fulvio Conti |
16,166 |
Simon Fraser |
23,349 |
Antony Jenkins |
613,084 |
Reuben Jeffery III |
33,162 |
Dambisa Moyo |
5,563 |
Frits van Paasschen |
500 |
Sir Michael Rake |
12,111 |
Diane de Saint Victor |
987 |
Sir John Sunderland |
25,399 |
Sir David Walker |
23,003 |
Peter Estlin |
12,966 |
Mark Harding |
11,301 |
Shaygan Kheradpir |
44,826 |
Robert Le Blanc |
132,325 |
Skip McGee* |
351,494 |
Sir Hector Sants |
60 |
Valerie Soranno Keating |
35,518 |
Ashok Vaswani |
9,996 |
*Skip McGee acquired 1,592 of his ordinary shares in the form of American Depositary Shares ("ADS"). One ADS is equivalent to four ordinary shares of the Company.
On 4 October 2013, the Company was notified that, following the Rights Issue period completed by the Company on 4 October 2013 and pursuant to the rules of the Company's share plans, adjustments had been made to awards and options granted under those plans to participants to take account of the Rights Issue on the basis described below. In accordance with the rules of certain of the Company's share plans, the Company's auditors have confirmed that the adjustments are fair and reasonable and HM Revenue & Customs have approved the adjustments to options outstanding under those of the Company's share plans that have been approved by them.
The adjustments operate so as to increase the number of Shares subject to options and awards by a factor of 1.08254887762 and, in the case of options, to reduce the exercise price per share by a factor of 0.92374581939. The adjustments to the awards and options held by Directors and PDMRs of the Company under each plan are set out below.
1. The Company made adjustments to options over Shares granted under the Barclays Group SAYE Share Option Scheme (Sharesave), being an HM Revenue & Customs approved all-employee share plan, including options for the following PDMRs:
PDMR |
Number of Shares under Option before adjustment |
Number of Shares under Option following adjustment |
Exercise price following adjustment (whole pence) |
|
|
|
|
|
|
Peter Estlin |
6,250 |
6,765 |
133 |
|
Ashok Vaswani |
6,255 |
6,771 |
228 |
|
2. The Company made adjustments to conditional rights granted by it over Shares under the Barclays Group Share Value Plan (SVP), including awards for the following PDMRs:
PDMR |
Number of Shares under Award before adjustment |
Number of Shares under Award following adjustment |
|
|
|
Tom King |
750,162 |
812,087 |
Irene McDermott Brown |
7,402 |
8,013 |
3. The Company made adjustments to options granted over Shares under the Barclays Incentive Share Option Plan (ISOP) in 2004 for the following PDMRs:
PDMR |
Number of Shares under Option before adjustment |
Number of Shares under Option following adjustment |
Exercise price following adjustment (whole pence) |
Mark Harding
|
82,144 |
88,924 |
431 |
Robert Le Blanc |
184,823 |
200,079 |
431 |
4. The Company was notified that unvested matching Shares under the Barclays Global Sharepurchase Plan were adjusted by the Company for the following PDMRs:
PDMR |
Number of unvested matching Shares under Award before adjustment |
Number of unvested matching Shares under Award following adjustment |
Skip McGee* |
404 |
436 |
*Held in the form of ADS
The nominee of the Barclays Nominee notified the Company on 7 October 2013 that on 7 October 2013 it sold ordinary shares of the Company at a price of 272 pence per share for the following PDMR:
PDMR |
Shares sold |
Ashok Vaswani |
48,734 |
The revised total shareholdings of the Directors following these transactions are as follows:
Director
|
Beneficial Holding |
Non-Beneficial Holding |
David Booth |
122,310 |
- |
Tim Breedon |
6,679 |
- |
Fulvio Conti |
80,834 |
- |
Simon Fraser |
116,744 |
- |
Antony Jenkins |
3,065,602 |
- |
Reuben Jeffery III* |
165,822 |
- |
Dambisa Moyo |
27,814 |
- |
Frits van Paasschen** |
2,500 |
- |
Sir Michael Rake |
60,556 |
- |
Diane de Saint Victor |
4,937 |
- |
Sir John Sunderland |
126,997 |
- |
Sir David Walker |
115,017 |
- |
*R Jeffery holds 125,432 of his ordinary shares in the form of ADS.
** F van Paasschen holds his shares in the form of ADS.